Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2018 000 025.6 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Telotristat oder ein pharmazeutisch akzeptables Salz oder Solvat davon, einschließlich Telotristatethyl |
54 | Title of basic patent | TIGZ | AUF 4-PHENYL-6-(2,2,2-TRIFLUOR-1-PHENYLETHOXY)PYRIMIDIN BASIERENDE VERBINDUNGEN UND VERWENDUNGSVERFAHREN |
51 | IPC main class | ICM (ICMV) | C07D 401/12 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 403/12 (2006.01), C07D 405/12 (2006.01), C07D 409/12 (2006.01), C07D 413/12 (2006.01), C07D 417/12 (2006.01), A61P 1/00 (2006.01), A61P 9/00 (2006.01), A61P 11/00 (2006.01), A61K 31/4152 (2006.01), A61K 31/506 (2006.01), C07D 239/34 (2006.01) |
94 | Start of term of protection | LB | Dec 12, 2027 |
94 | End of term of protection | LE | Sep 20, 2032 |
22 | DE application date | DAT | Feb 20, 2018 |
| Date of publication of application for a certificate | OT | Apr 5, 2018 |
| Date of publication of grant of certificate | PET | May 29, 2019 |
71/73 | Applicant/owner | INH | TerSera Therapeutics LLC, 520 Lake Cook Road, Suite 500, 60015 Deerfield, IL, US |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
| Due date | FT FG | Dec 31, 2027 Annual fee for the 21st year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2007 044 218.4 |
68 | EP file number of basic patent | GEAKZ | 07 86 5487.8 |
43 | Date of first publication | EVT | Apr 5, 2018 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/17/1224 2017-09-18
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/17/1224 2017-09-18
|
| Date of the first transfer into DPMAregister | EREGT | Apr 5, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 20, 2024 (Show all update days)(Hide all update days)- Jul 20, 2024
- St.36: changed (technical change)
- Nov 25, 2023; Jan 26, 2022; Mar 4, 2021; Jul 16, 2019; May 29, 2019; Apr 26, 2019; Feb 23, 2019
- Historical data not available for this/these date(s)
- Apr 5, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 4)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 3, 2021 |
71/73 | Applicant/owner | INH | TerSera Therapeutics LLC, 60015 Deerfield, IL, US |
71/73 | Previous applicant/owner | INHF | Lexicon Pharmaceuticals, Inc., 77381 The Woodlands, Tex., US |
| Date of update of the procedure | REGT | Mar 4, 2021 |